Scott Gridley

Scott Gridley currently serves as Business Development Director at APC Ltd, focusing on enhancing the delivery of critical medicines through strategic partnerships and R&D services. Previous roles include Business Development Executive at Emulate, Inc. and Senior Director of Business Development at Organovo Holdings, Inc., where Scott contributed to the advancement of 3D bioprinted tissues for drug discovery and treatment modeling. Scott's career also includes significant positions such as Vice President of Business Development at Blue Sky BioServices, where strategic client partnerships and sales team management were paramount, and a Postdoctoral Fellow at Dartmouth Medical School, where innovative research on insulin-responsive proteins was conducted. Scott holds a Ph.D. in Biochemistry from the Geisel School of Medicine at Dartmouth and a B.S. in Microbiology from Rutgers University.